Pinnacle Associates LTD Regeneron Pharmaceuticals, Inc. Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 66,965 shares of REGN stock, worth $47 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

66,965

Previous 66,354 0.92%

Holding current value

$47 Million

Previous $69.7 Million 0.94%

% of portfolio

1.12%

Previous 1.12%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$1024.09 - $1201.76 $625,718 - $734,275	611 Added 0.92%	66,965 $70.4 Million
Q2 2024 Jul 30, 2024	SELL	$883.2 - $1071.19 $137,779 - $167,105	-156 Reduced 0.23%	66,354 $69.7 Million
Q1 2024 Apr 26, 2024	SELL	$902.69 - $993.35 $410,723 - $451,974	-455 Reduced 0.68%	66,510 $64 Million
Q4 2023 Jan 19, 2024	SELL	$775.18 - $881.7 $401,543 - $456,720	-518 Reduced 0.77%	66,965 $58.8 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $1.88 Million - $2.29 Million	-2,712 Reduced 3.86%	67,483 $55.5 Million
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $1.05 Million - $1.25 Million	-1,504 Reduced 2.1%	70,195 $50.4 Million
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $878,512 - $1.07 Million	-1,291 Reduced 1.77%	71,699 $58.9 Million
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $646,595 - $702,013	916 Added 1.27%	72,990 $52.7 Million
Q4 2022 Jan 25, 2023	SELL	$705.89 - $766.39 $1.02 Million - $1.11 Million	-1,443 Reduced 1.96%	72,074 $0
Q3 2022 Oct 31, 2022	SELL	$573.97 - $724.32 $8.71 Million - $11 Million	-15,171 Reduced 17.11%	73,517 $50.6 Million
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $1.65 Million - $2.23 Million	-3,013 Reduced 3.29%	88,688 $52.4 Million
Q1 2022 May 05, 2022	SELL	$595.12 - $698.43 $2.26 Million - $2.65 Million	-3,794 Reduced 3.97%	91,701 $64 Million
Q4 2021 Feb 02, 2022	SELL	$543.48 - $670.97 $773,915 - $955,461	-1,424 Reduced 1.47%	95,495 $60.3 Million
Q3 2021 Oct 19, 2021	SELL	$574.03 - $680.96 $1.41 Million - $1.68 Million	-2,462 Reduced 2.48%	96,919 $58.7 Million
Q2 2021 Aug 02, 2021	SELL	$472.8 - $558.54 $524,808 - $619,979	-1,110 Reduced 1.1%	99,381 $55.5 Million
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $2.39 Million - $2.93 Million	-5,344 Reduced 5.05%	100,491 $47.5 Million
Q4 2020 Jan 26, 2021	SELL	$478.3 - $607.98 $2.34 Million - $2.97 Million	-4,885 Reduced 4.41%	105,835 $51.1 Million
Q3 2020 Oct 23, 2020	SELL	$544.75 - $658.21 $1.17 Million - $1.42 Million	-2,156 Reduced 1.91%	110,720 $62 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $3.44 Million - $4.49 Million	-6,970 Reduced 5.82%	112,876 $70.4 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $7.38 Million - $10.8 Million	-21,943 Reduced 15.48%	119,846 $58.5 Million
Q4 2019 Feb 03, 2020	SELL	$274.13 - $376.51 $3.61 Million - $4.96 Million	-13,171 Reduced 8.5%	141,789 $53.2 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $1.9 Million - $2.21 Million	-6,944 Reduced 4.29%	154,960 $43 Million
Q2 2019 Aug 05, 2019	SELL	$299.6 - $414.82 $2.79 Million - $3.86 Million	-9,312 Reduced 5.44%	161,904 $50.7 Million
Q1 2019 May 10, 2019	SELL	$372.08 - $439.57 $2.32 Million - $2.74 Million	-6,236 Reduced 3.51%	171,216 $70.3 Million
Q4 2018 Feb 05, 2019	SELL	$335.82 - $403.04 $4.26 Million - $5.12 Million	-12,699 Reduced 6.68%	177,452 $66.3 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $7.97 Million - $9.27 Million	-22,689 Reduced 10.66%	190,151 $76.8 Million
Q2 2018 Aug 08, 2018	SELL	$284.6 - $344.99 $8.03 Million - $9.73 Million	-28,203 Reduced 11.7%	212,840 $73.4 Million
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $1.17 Million - $1.46 Million	-3,715 Reduced 1.52%	241,043 $83 Million
Q4 2017 Feb 12, 2018	SELL	$358.63 - $469.95 $6.94 Million - $9.09 Million	-19,349 Reduced 7.33%	244,758 $92 Million
Q3 2017 Nov 13, 2017	SELL	$431.38 - $504.0 $1.48 Million - $1.73 Million	-3,424 Reduced 1.28%	264,107 $118 Million
Q2 2017 Aug 09, 2017	BUY	N/A	267,531	267,531 $131 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Regeneron Pharmaceuticals, Inc. Transaction History